Rankings
▼
Calendar
KMDA Q4 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$32M
-1.6% YoY
Gross Profit
$10M
32.2% margin
Operating Income
$3M
8.4% margin
Net Income
$2M
5.2% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
-10.7%
Cash Flow
Operating Cash Flow
$14M
Free Cash Flow
$11M
Stock-Based Comp.
$124,000
Balance Sheet
Total Assets
$211M
Total Liabilities
$32M
Stockholders' Equity
$179M
Cash & Equivalents
$70M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$32M
$32M
-1.6%
Gross Profit
$10M
$12M
-15.9%
Operating Income
$3M
$5M
-51.7%
Net Income
$2M
$5M
-69.6%
← FY 2020
All Quarters
Q1 2021 →